The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak
Telemedicine and e-Health, Ahead of Print. Source link
Read moreTelemedicine and e-Health, Ahead of Print. Source link
Read moreAim: This article reviews the studies examining patients’ perspective toward telemedicine and their preference for virtual health care services. Methods:
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read more© American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is qualified 501(c)(3) tax-exempt organization.*Red
Read morePhilipp Lurz Correspondence to: Philipp Lurz, MD PhD, Department of Internal Medicine/Cardiology, Heart Center Leipzig, University of Leipzig, Strümpellstraße 39,
Read moreJonathan D. Rich Correspondence to: Jonathan D. Rich, MD, Northwestern University, Feinberg School of Medicine, Medical Director, Mechanical Circulatory Support
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreBackground: The net clinical benefit of cardiac disease-modifying drugs might be influenced by the interaction of different domains of disease
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read more